Latest Breaking News On - Presse financi - Page 1 : comparemela.com

Pharnext Sa : Edison Investment Research maintains its valuation following the Company s latest announcements -September 26, 2023 at 04:35 am EDT

PARIS, France, September 26, 2023 at 08:30 am CET – Pharnext SCA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with.

France generalUnited statesAnne charlotte dudicourtFabreguettes leibEdison investment researchEdison groupEuronext growthPresse financi

PHARNEXT: Edison Investment Research maintains its valuation following the Company s latest announcements

PHARNEXT: Edison Investment Research maintains its valuation following the Company s latest announcements
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Baden wübergFrance generalUnited statesAnne charlotte dudicourtFabreguettes leibEdison groupEdison investment researchEuronext growthPresse financi

Dr Gilbert Wagener brings to Pharnext 30 years of experience in medical affairs and R&D in various therapeutic areas, including neurological and/or rare diseases, and on products at various. | June 15, 2023

United statesFrance generalFabreguettes leibGenzyme europeGilbert wagenerHugo brugiGerman society of physiologyEuronext growth stock exchangeErasmus universityMarburg university hospitalsEuropean society of cardiologyRegenerative medicine advisory committeeGerman society of pharmacologyEpidemiology public healthUniversity of baselEuropean society of hypertension

PHARNEXT: Pharnext appoints Gilbert Wagener, M D , Ph D as Chief Medical Officer

PHARNEXT: Pharnext appoints Gilbert Wagener, M D , Ph D as Chief Medical Officer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesFrance generalGilbert wagenerHugo brugiGenzyme europeFabreguettes leibGerman society of pharmacologyUniversity of baselEuronext growth stock exchangeEuropean society of hypertensionSenior partner at transcrip partnersEuropean society of cardiologyMarburg university hospitalsErasmus universityGerman society of physiologyEpidemiology public health

PARIS, France, June 14th, 2023, 08:30 am CET – Pharnext SA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high. | June 14, 2023

United statesFrance generalFabreguettes leibBella centerEuronext growth stock exchangePeripheral nerve societyPresse financiPharnext sa stock exchangePress releaseIth alpha fr001400gun7